课题基金 / 基金详情

Exploring the role of HOCI in skin photodamage, immunosuppression, and carcinogenesis

Exploring the role of HOCI in skin photodamage, immunosuppression, and carcinogenesis
探索 HOCI 在皮肤光损伤、免疫抑制和癌变中的作用
批准号:
9904653
负责人:
Georg T Wondrak
金额:
$18.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-01 至 2021-03-31

项目摘要

项目成果

Georg T Wondrak的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Hypochlorous acid (HOCl) is the active oxidizing principle released by standard swimming pool disinfectants used on a global scale, but the health consequences of human exposure inflicted by HOCl remain largely unknown, posing a major public health concern relevant to populations around the world. Environmental exposure to solar ultraviolet (UV) radiation is a causative factor in skin photocarcinogenesis, and immune suppression is a key mechanism underlying detrimental effects of acute and chronic UV exposure. Based on our prototype experiments, the proposed research will explore the molecular potentiation of UV-induced cutaneous and systemic damage by co-exposure to HOCl-based swimming pool disinfectants, examined in cell culture, skin tissue models, and mouse models of UV-induced skin damage and cancer. First, we will define the specific molecular mechanisms underlying HOCl-potentiation of solar UV-induced oxidative insult and genotoxic stress, examined in cultured skin cells and human epidermal tissue reconstructs (aim #1). Next, we will explore the potentiating role of HOCl co-exposure in established murine models of UV-induced acute photodamage (sunburn), systemic photoimmunosuppression, and photocarcinogenesis (aim #2). The
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Repurposing Clinical ACT Antimalarials for Experimental Melanoma Intervention
  • 批准号:
    10549763
  • 项目类别:
  • 资助金额:
    $32.88万
  • 财政年份:
    2019
  • 负责人:
    Georg T Wondrak
  • 依托单位:
Repurposing Clinical ACT Antimalarials for Experimental Melanoma Intervention
  • 批准号:
    10093984
  • 项目类别:
  • 资助金额:
    $33.78万
  • 财政年份:
    2019
  • 负责人:
    Georg T Wondrak
  • 依托单位:
Repurposing Clinical ACT Antimalarials for Experimental Melanoma Intervention
  • 批准号:
    10333277
  • 项目类别:
  • 资助金额:
    $32.99万
  • 财政年份:
    2019
  • 负责人:
    Georg T Wondrak
  • 依托单位:
Project 1: TLR4 as a Novel Target for Skin Cancer Prevention
  • 批准号:
    10475132
  • 项目类别:
  • 资助金额:
    $19.43万
  • 财政年份:
    2019
  • 负责人:
    Georg T Wondrak
  • 依托单位:
海外基金